Celldex Therapeutics (CLDX) Times Interest Earned (2010 - 2013)
Celldex Therapeutics (CLDX) recorded quarterly Times Interest Earned of -$260.16 in Q4 2013, up 85.47% quarter-over-quarter from -$1789.9 in Q3 2013, and down 451.77% on a YoY basis from $73.96 in Q4 2012.
Celldex Therapeutics (CLDX) Times Interest Earned (2010 - 2013) Analysis & Trends
Celldex Therapeutics' Times Interest Earned history runs 4 years deep, the most recent figure standing at -$260.16 for Q4 2013.
- In Q4 2013, Times Interest Earned fell 451.77% year-over-year to -$260.16; the TTM figure through Sep 2014 stood at -$1323.5 (down 1980.82% YoY), while the FY2013 annual figure was -$87.86, down 138.41% from the prior year.
- Times Interest Earned was -$260.16 for Q4 2013 at Celldex Therapeutics, up from -$1789.9 in the prior quarter.
- In the past five years, Times Interest Earned ranged from a high of $63.03 in Q4 2010 to a low of -$1789.9 in Q3 2013.
- Historically, Times Interest Earned has averaged -$158.68 across 4 years, with a median of -$30.69 in 2012.
- The sharpest annual moves came in 2011 and 2013: Times Interest Earned grew 18.11% in 2011, then plunged 4523.15% in 2013.
- A 4-year view of Times Interest Earned shows it stood at $63.03 in 2010, then sank by 144.85% to -$28.27 in 2011, then sank by 66.78% to -$47.15 in 2012, then tumbled by 451.77% to -$260.16 in 2013.
- The last three Times Interest Earned figures came in at -$260.16 (Q4 2013), -$1789.9 (Q3 2013), and -$35.95 (Q2 2013), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Times Interest Earned (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 3.58 |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | 11.50 |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | -258.33 |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | 547.67 |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | - |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | 11.79 |
| 10 | Celldex Therapeutics | 2.16 Bn | 2.16 Bn | -1.44 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2013 | -260.16 |
| Sep 30, 2013 | -1,789.92 |
| Jun 30, 2013 | -35.95 |
| Mar 31, 2013 | -56.13 |
| Dec 31, 2012 | -47.15 |
| Sep 30, 2012 | -38.72 |
| Jun 30, 2012 | -32.82 |
| Mar 31, 2012 | -30.69 |
| Dec 31, 2011 | -28.27 |
| Sep 30, 2011 | -26.21 |
| Jun 30, 2011 | -22.77 |
| Mar 31, 2011 | -19.91 |
| Dec 31, 2010 | 63.03 |
| Sep 30, 2010 | -26.74 |
| Jun 30, 2010 | -27.80 |